reference/8465690

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8465690

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial
endingPage	2006
issn	0264-410X
issueIdentifier	15
pageRange	2004-2006
publicationName	Vaccine
startingPage	2004
bibliographicCitation	Perrin L. Therapeutic vaccination in primary HIV infection, the Quest1Quest Core Group and Research Team: D. Cooper, Australia; B. Hoen, France; S. Kinloch, UK; A. Phillips, UK; C. Tsoukas, Canada; J. Andersson, Sweden; F. Lampe, UK; B. Autran, France; G. Janossy, UK; V. Miller, Germany; Z. Racz, Germany; R. Sekaly, Canada; clinicians in more than 20 recruiting centres and the supporting team of GlaxoSmithKline: V. Mallet, S. Turkish, S. Fortes, C. Python, M. Haberl and Li-Ean Goh, Quest project leader UK. Industry collaborators—main sponsor: GlaxoSmithKline, Hugh Mc Dade; Roche Molecular Systems: B. Dale, A. Capt; Immune Response Corporation: R. Moss, J. Dively.1 trial. Vaccine. 2002 May;20(15):2004–6. doi: 10.1016/s0264-410x(02)00087-7.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5192113aec2995bf50085a4b1163d5f
date	2002-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1016/s0264-410x%2802%2900087-7 https://pubmed.ncbi.nlm.nih.gov/11983263
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7945 https://portal.issn.org/resource/ISSN/0264-410X
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Therapeutic vaccination in primary HIV infection, the Quest1Quest Core Group and Research Team: D. Cooper, Australia; B. Hoen, France; S. Kinloch, UK; A. Phillips, UK; C. Tsoukas, Canada; J. Andersson, Sweden; F. Lampe, UK; B. Autran, France; G. Janossy, UK; V. Miller, Germany; Z. Racz, Germany; R. Sekaly, Canada; clinicians in more than 20 recruiting centres and the supporting team of GlaxoSmithKline: V. Mallet, S. Turkish, S. Fortes, C. Python, M. Haberl and Li-Ean Goh, Quest project leader UK. Industry collaborators—main sponsor: GlaxoSmithKline, Hugh Mc Dade; Roche Molecular Systems: B. Dale, A. Capt; Immune Response Corporation: R. Moss, J. Dively.1 trial
discusses	http://id.nlm.nih.gov/mesh/M0277557 http://id.nlm.nih.gov/mesh/M0028682 http://id.nlm.nih.gov/mesh/M0023387 http://id.nlm.nih.gov/mesh/M0020790 http://id.nlm.nih.gov/mesh/M0274271 http://id.nlm.nih.gov/mesh/M0028839 http://id.nlm.nih.gov/mesh/M0003327 http://id.nlm.nih.gov/mesh/M0025741 http://id.nlm.nih.gov/mesh/M0008898 http://id.nlm.nih.gov/mesh/M0023377 http://id.nlm.nih.gov/mesh/M0022738 http://id.nlm.nih.gov/mesh/M0250495 http://id.nlm.nih.gov/mesh/M0442353
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D016915Q000627 http://id.nlm.nih.gov/mesh/D023241 http://id.nlm.nih.gov/mesh/D016233 http://id.nlm.nih.gov/mesh/D014766Q000628 http://id.nlm.nih.gov/mesh/D015658Q000628
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D019562 http://id.nlm.nih.gov/mesh/D015215Q000627 http://id.nlm.nih.gov/mesh/D014611 http://id.nlm.nih.gov/mesh/D013449Q000627 http://id.nlm.nih.gov/mesh/D018655 http://id.nlm.nih.gov/mesh/D003131 http://id.nlm.nih.gov/mesh/D016915Q000235 http://id.nlm.nih.gov/mesh/D003673Q000276 http://id.nlm.nih.gov/mesh/D014765Q000276 http://id.nlm.nih.gov/mesh/D014766Q000473 http://id.nlm.nih.gov/mesh/D016176Q000276 http://id.nlm.nih.gov/mesh/D014616Q000276 http://id.nlm.nih.gov/mesh/D014616Q000235 http://id.nlm.nih.gov/mesh/D015224Q000627 http://id.nlm.nih.gov/mesh/D002219 http://id.nlm.nih.gov/mesh/D018414Q000473 http://id.nlm.nih.gov/mesh/D018414Q000276 http://id.nlm.nih.gov/mesh/D014766Q000276 http://id.nlm.nih.gov/mesh/D014766Q000188 http://id.nlm.nih.gov/mesh/D015658Q000276 http://id.nlm.nih.gov/mesh/D003673Q000235 http://id.nlm.nih.gov/mesh/D015658Q000188 http://id.nlm.nih.gov/mesh/D019259Q000627 http://id.nlm.nih.gov/mesh/D015658Q000473 http://id.nlm.nih.gov/mesh/D005663 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D019380Q000627

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129815097 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128324017 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128575040

Total number of triples: 66.